The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
MESALAZINE SUN/ MESALZ (Sun Pharma ANZ Pty Ltd)
Product name
MESALAZINE SUN/ MESALZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
129 (255 working days)
Active ingredients
Mesalazine
Registration type
New generic medicine
Indication
For the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.